By Associate Professor Min Jun

Journal articles

Weaver RG; James MT; Ravani P; Weaver CGW; Lamb EJ; Tonelli M; Manns BJ; Quinn RR; Jun M; Hemmelgarn BR, 2020, 'Estimating urine albumin-to-creatinine ratio from protein-to-creatinine ratio: Development of Equations using Same-Day Measurements', Journal of the American Society of Nephrology, 31, pp. 591 - 601, http://dx.doi.org/10.1681/ASN.2019060605

Lo C; Toyama T; Oshima M; Jun M; Chin KL; Hawley CM; Zoungas S, 2020, 'Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients', COCHRANE DATABASE OF SYSTEMATIC REVIEWS, http://dx.doi.org/10.1002/14651858.cd009956.pub3

Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group , 2020, 'KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.', Kidney Int, 98, pp. S1 - S115, http://dx.doi.org/10.1016/j.kint.2020.06.019

Liyanage T; Toyama T; Ninomiya T; Perkovic V; Woodward M; Fukagawa M; Matsushita K; Praditpornsilpa K; Seong HL; Iseki K; Lin MY; Stirnadel-Farrant HA; Jha V; Jun M, 2020, 'SUN-107 THE PREVALENCE OF CHRONIC KIDNEY DISEASE IN ASIA – A SYSTEMATIC REVIEW AND ANALYSIS', Kidney International Reports, 5, pp. S245 - S245, http://dx.doi.org/10.1016/j.ekir.2020.02.634

OSHIMA M; Wong MG; Hara A; Toyama T; Jun M; Jardine M; Pollock C; Woodward M; Chalmers J; Perkovic V; Wada T, 2020, 'SUN-161 CIRCULATING AUTOANTIBODIES TO ERYTHROPOIETIN RECEPTOR AND KIDNEY DISEASE PROGRESSION IN TYPE 2 DIABETES MELLITUS: RESULTS FROM THE ADVANCE STUDIES', Kidney International Reports, 5, pp. S267 - S267, http://dx.doi.org/10.1016/j.ekir.2020.02.690

Oshima M; Jun M; Ohkuma T; Toyama T; Wada T; Cooper ME; Hadjadj S; Hamet P; Harrap S; Mancia G; Marre M; Williams B; Chalmers J; Woodward M; Perkovic V, 2019, 'The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study', Diabetologia, 62, pp. 1988 - 1997, http://dx.doi.org/10.1007/s00125-019-4948-4

Gray NA; Zuo L; Hong D; Smyth B; Jun M; De Zoysa J; Vo K; Howard K; Wang J; Lu C; Liu Z; Cass A; Perkovic V; Jardine M, 2019, 'Quality of life in caregivers compared with dialysis recipients: The Co-ACTIVE sub-study of the ACTIVE dialysis trial', Nephrology, 24, pp. 1056 - 1063, http://dx.doi.org/10.1111/nep.13530

Ha JT; Neuen BL; Cheng LP; Jun M; Toyama T; Gallagher MP; Jardine MJ; Sood MM; Garg AX; Palmer SC; Mark PB; Wheeler DC; Jha V; Freedman B; Johnson DW; Perkovic V; Badve SV, 2019, 'Benefits and harms of oral anticoagulant therapy in chronic kidney disease', Annals of Internal Medicine, 171, pp. 181 - 189, http://dx.doi.org/10.7326/M19-0087

Toyama T; NEUEN B; Jun M; Ohkuma T; Neal B; Jardine M; Heerspink H; Ninomiya T; Wada T; Perkovic V, 2019, 'SAT-298 EFFECT OF SGLT2 INHIBITORS ON CARDIOVASCULAR, RENAL AND SAFETY OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE', Kidney International Reports, 4, pp. s133, http://dx.doi.org/10.1016/j.ekir.2019.05.338

Ohkuma T; Jun M; Chalmers J; Cooper ME; Hamet P; Harrap S; Zoungas S; Perkovic V; Woodward M, 2019, 'Combination of changes in estimated GFR and albuminuria and the risk of major clinical outcomes', Clinical Journal of the American Society of Nephrology, 14, pp. 862 - 872, http://dx.doi.org/10.2215/CJN.13391118

Toyama T; Neuen BL; Jun M; Ohkuma T; Neal B; Jardine MJ; Heerspink HL; Wong MG; Ninomiya T; Wada T; Perkovic V, 2019, 'Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis', Diabetes, Obesity and Metabolism, 21, pp. 1237 - 1250, http://dx.doi.org/10.1111/dom.13648

Ha JT; Badve SV; Jun M, 2019, 'Recent evidence for direct oral anticoagulants in chronic kidney disease', Current Opinion in Nephrology and Hypertension, 28, pp. 251 - 261, http://dx.doi.org/10.1097/mnh.0000000000000493

Jun M; Jardine MJ; Perkovic V; Pilard Q; Billot L; Rodgers A; Rogers K; Gallagher M, 2019, 'Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study', PLoS ONE, 14, pp. e0213192, http://dx.doi.org/10.1371/journal.pone.0213192

Ohkuma T; Jun M; Rodgers A; Cooper ME; Glasziou P; Hamet P; Harrap S; Mancia G; Marre M; Neal B; Perkovic V; Poulter N; Williams B; Zoungas S; Chalmers J; Woodward M, 2019, 'Acute Increases in Serum Creatinine after Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial', Hypertension, 73, pp. 84 - 91, http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12060

Harrison TG; Tam-Tham H; Hemmelgarn BR; Elliott M; James MT; Ronksley PE; Jun M, 2019, 'Change in Proteinuria or Albuminuria as a Surrogate for Cardiovascular and Other Major Clinical Outcomes: A Systematic Review and Meta-analysis', Canadian Journal of Cardiology, 35, pp. 77 - 91, http://dx.doi.org/10.1016/j.cjca.2018.10.014

Turakhia MP; Blankestijn PJ; Carrero JJ; Clase CM; Deo R; Herzog CA; Kasner SE; Passman RS; Pecoits-Filho R; Reinecke H; Shroff GR; Zareba W; Cheung M; Wheeler DC; Winkelmayer WC; Wanner C; Amann K; Banerjee D; Bansal N; Boriani G; Bunch J; Chan CT; Charytan DM; Conen D; Friedman AN; Genovesi S; Holden RM; House AA; Jadoul M; Jar-Dine AG; Johnson DW; Jun M; Labriola L; Mark PB; McCullough PA; Nolin TD; Potpara TS; Pun PH; Ribeiro ALP; Rossignol P; Shen JI; Sood MM; Tsukamoto Y; Yee-Moon Wang A; Weir MR; Wetmore JB; Wranicz JK; Yamasaki H, 2019, 'CHRONIC KIDNEY DISEASE AND ARRHYTHMIAS: CONCLUSIONS FROM A KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO) CONTROVERSIES CONFERENCE', Nephrology (Saint-Petersburg), 23, pp. 18 - 40, http://dx.doi.org/10.24884/1561-6274-2019-23-2-18-40

Ohkuma T; Zoungas S; Jun M; Lisheng L; Mancia G; Marre M; Rodgers A; Williams B; Woodward M; Chalmers J, 2019, 'Intensive glucose-lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial', Diabetes, Obesity and Metabolism, 22, pp. 452 - 457, http://dx.doi.org/10.1111/dom.13878

Sukkar L; Talbot B; Jun M; Dempsey E; Walker R; Hooi L; Cass A; Jardine M; Gallagher M, 2019, 'Protocol for the Study of Heart and Renal Protection-Extended Review: Additional 5-Year Follow-up of the Australian, New Zealand, and Malaysian SHARP Cohort', Canadian Journal of Kidney Health and Disease, 6, pp. 2054358119879896, http://dx.doi.org/10.1177/2054358119879896

HOCKHAM C; Kang A; Young T; Sukkar L; Jun M; Rogers K; Baker J; Cass A; Jardine M, 2019, 'SAT-241 SMALL AREA-LEVEL VARIATION IN CHRONIC KIDNEY DISEASE PREVALENCE AND INCIDENCE IN NEW SOUTH WALES', Kidney International Reports, 4, pp. S108 - S108, http://dx.doi.org/10.1016/j.ekir.2019.05.277

OSHIMA M; Jun M; Toyama T; Perkovic V; Chalmers J; Woodward M, 2019, 'SAT-287 eGFR SLOPE AND THE SUBSEQUENT RISK OF CLINICAL OUTCOMES IN TYPE 2 DIABETES', Kidney International Reports, 4, pp. S128 - S128, http://dx.doi.org/10.1016/j.ekir.2019.05.325

YOUNG T; Hockham C; Sukkar L; Kang A; Jun M; Baker J; Rogers K; Cass A; Jardine M, 2019, 'SAT-288 Trends in pharmacotherapy for diabetes in a large Australian cohort: results from the EXTEND45 study', Kidney International Reports, 4, pp. S128 - S129, http://dx.doi.org/10.1016/j.ekir.2019.05.326

Young T; Hockham C; Sukkar L; Kang A; Jun M; Baker J; Rogers K; Cass A; Jardine M, 2019, 'SAT-289 Association between the intensity of diabetes pharmacotherapy regimens, persistence and achieved HbA1c in a large Australian cohort: results from the EXTEND45 study', Kidney International Reports, 4, pp. S129 - S129, http://dx.doi.org/10.1016/j.ekir.2019.05.327

JUN M; Ohkuma T; Woodward M; Chalmers J; Zoungas S, 2019, 'SAT-294 RANDOMISED EFFECTS OF INTENSIVE GLUCOSE-LOWERING THERAPY ON THE RISK OF MAJOR CLINICAL OUTCOMES IN TYPE 2 DIABETES ACCORDING TO eGFR AND UACR LEVELS', Kidney International Reports, 4, pp. S131 - S131, http://dx.doi.org/10.1016/j.ekir.2019.05.334

TALBOT B; Lin R; Sagar P; Sen S; Jun M; Gallagher M, 2019, 'SUN-057 Reducing Central Venous Catheter Burden in Haemodialysis Patients: The Impact of Changing Practice within an Australian Renal Unit', Kidney International Reports, 4, pp. S178 - S178, http://dx.doi.org/10.1016/j.ekir.2019.05.453

TALBOT B; Sagar P; Lin R; Jun M; Sen S; Gallagher M, 2019, 'SUN-178 The Impact of Acute Kidney Injury Requiring Haemodialysis on Patient Survival: 10 Years of Prospective Data', Kidney International Reports, 4, pp. S232 - S232, http://dx.doi.org/10.1016/j.ekir.2019.05.580

Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S, 2018, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD011798.pub2

Peng T; Zhuo L; Wang Y; Jun M; Li G; Wang L; Hong D, 2018, 'Systematic review of sodium thiosulfate in treating calciphylaxis in chronic kidney disease patients', Nephrology, 23, pp. 669 - 675, http://dx.doi.org/10.1111/nep.13081

Turakhia MP; Blankestijn PJ; Carrero J-J; Clase CM; Deo R; Herzog CA; Kasner SE; Passman RS; Pecoits-Filho R; Reinecke H; Shroff GR; Zareba W; Cheung M; Wheeler DC; Winkelmayer WC; Wanner C, 2018, 'Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference', EUROPEAN HEART JOURNAL, 39, pp. 2314 - +, http://dx.doi.org/10.1093/eurheartj/ehy060

Eckardt KU; Bansal N; Coresh J; Evans M; Grams ME; Herzog CA; James MT; Heerspink HJL; Pollock CA; Stevens PE; Tamura MK; Tonelli MA; Wheeler DC; Winkelmayer WC; Cheung M; Hemmelgarn BR; Abu-Alfa AK; Anand S; Arici M; Ballew SH; Block GA; Burgos-Calderon R; Charytan DM; Das-Gupta Z; Dwyer JP; Fliser D; Froissart M; Gill JS; Griffith KE; Harris DC; Huffman K; Inker LA; Jager KJ; Jun M; Kalantar-Zadeh K; Kasiske BL; Kovesdy CP; Krane V; Lamb EJ; Lerma EV; Levey AS; Levin A; Julián Mauro JC; Nash DM; Navaneethan SD; O'Donoghue D; Obrador GT; Pecoits-Filho R; Robinson BM; Schäffner E; Segev DL; Stengel B; Stenvinkel P; Tangri N; Tentori F; Tsukamoto Y; Turakhia MP; Vazquez MA; Yee-Moon Wang A; Williams AW, 2018, 'Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference', Kidney International, 93, pp. 1281 - 1292, http://dx.doi.org/10.1016/j.kint.2018.02.006

Jun M; Ohkuma T; Zoungas S; Colagiuri S; Mancia G; Marre M; Matthews D; Poulter N; Williams B; Rodgers A; Perkovic V; Chalmers J; Woodward M, 2018, 'Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results from ADVANCE-ON', Diabetes Care, 41, pp. 163 - 170, http://dx.doi.org/10.2337/dc17-1467

Galbraith L; Jacobs C; Hemmelgarn BR; Donald M; Manns BJ; Jun M, 2018, 'Chronic disease management interventions for people with chronic kidney disease in primary care: A systematic review and meta-analysis', Nephrology Dialysis Transplantation, 33, pp. 112 - 121, http://dx.doi.org/10.1093/ndt/gfw359

Jun M; Lix LM; Durand M; Dahl M; Paterson JM; Dormuth CR; Ernst P; Yao S; Renoux C; Tamim H; Wu C; Mahmud SM; Hemmelgarn BR, 2017, 'Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study', BMJ, 359, http://dx.doi.org/10.1136/bmj.j4323

Ohkuma T; Jun M; Woodward M; Zoungas S; Cooper ME; Grobbee DE; Hamet P; Mancia G; Williams B; Welsh P; Sattar N; Shaw JE; Rahimi K; Chalmers J, 2017, 'Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: The ADVANCE trial', Diabetes Care, 40, pp. 1203 - 1209, http://dx.doi.org/10.2337/dc17-0509

Ohkuma T; Woodward M; Jun M; Muntner P; Hata J; Colagiuri S; Harrap S; Mancia G; Poulter N; Williams B; Rothwell P; Chalmers J, 2017, 'Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study', Hypertension, 70, pp. 461 - 468, http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.09359

Gill S; Jun M; Ravani P, 2017, 'Atrial fibrillation and chronic kidney disease: Struggling through thick and thin', Nephrology Dialysis Transplantation, 32, pp. 1079 - 1084, http://dx.doi.org/10.1093/ndt/gfw378

Jun M; Hemmelgarn BR, 2017, 'In Reply to ‘International Normalized Ratio Control in Patients With Atrial Fibrillation and CKD’', American Journal of Kidney Diseases, 69, pp. 863 - 864, http://dx.doi.org/10.1053/j.ajkd.2017.02.368

Jun M; James MT; Ma Z; Zhang J; Tonelli M; McAlister FA; Manns BJ; Ravani P; Quinn RR; Wiebe N; Perkovic V; Wilton SB; Winkelmayer WC; Hemmelgarn BR, 2017, 'Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation', American Journal of Kidney Diseases, 69, pp. 734 - 743, http://dx.doi.org/10.1053/j.ajkd.2016.10.018

Elliott MJ; Gil S; Hemmelgarn BR; Manns BJ; Tonelli M; Jun M; Donald M, 2017, 'A scoping review of adult chronic kidney disease clinical pathways for primary care', Nephrology Dialysis Transplantation, 32, pp. 838 - 846, http://dx.doi.org/10.1093/ndt/gfw208

Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S, 2017, 'Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients', Cochrane Database of Systematic Reviews, 2017, http://dx.doi.org/10.1002/14651858.CD009966.pub2

McAlister FA; Wiebe N; Jun M; Sandhu R; James MT; McMurtry MS; Hemmelgarn BR; Tonelli M, 2017, 'Are Existing Risk Scores for Nonvalvular Atrial Fibrillation Useful for Prediction or Risk Adjustment in Patients With Chronic Kidney Disease?', Canadian Journal of Cardiology, 33, pp. 243 - 252, http://dx.doi.org/10.1016/j.cjca.2016.08.018

Turin TC; Saad N; Jun M; Tonelli M; Ma Z; Barnabe CCM; Manns B; Hemmelgarn B, 2016, 'Lifetime risk of diabetes among first nations and non-first nations people', CMAJ, 188, pp. 1147 - 1153, http://dx.doi.org/10.1503/cmaj.150787

Donald M; McBrien K; Jackson W; Manns BJ; Tonelli M; King-Shier K; Jindal K; Lewanczuk RZ; Scott-Douglas N; Braun T; Straus SE; Naugler C; Elliott MJ; Jun M; Hemmelgarn BR, 2016, 'Development and implementation of an online clinical pathway for adult chronic kidney disease in primary care: A mixed methods study', BMC Medical Informatics and Decision Making, 16, http://dx.doi.org/10.1186/s12911-016-0350-z

Liyanage T; Ninomiya T; Wang A; Neal B; Jun M; Wong MG; Jardine M; Hillis GS; Perkovic V; Jun M; Wang Y, 2016, 'Effects of the mediterranean diet on cardiovascular outcomes-a systematic review and meta-analysis', PLoS ONE, 11, pp. e0159252, http://dx.doi.org/10.1371/journal.pone.0159252

Ramesh S; Zalucky A; Hemmelgarn BR; Roberts DJ; Ahmed SB; Wilton SB; Jun M, 2016, 'Incidence of sudden cardiac death in adults with end-stage renal disease: A systematic review and meta-analysis', BMC Nephrology, 17, http://dx.doi.org/10.1186/s12882-016-0293-8

Jun M; Hemmelgarn BR, 2016, 'Strategies for BP control in developing countries and effects on kidney function', Clinical Journal of the American Society of Nephrology, 11, pp. 932 - 934, http://dx.doi.org/10.2215/CJN.03690316

Galbraith LE; Ronksley PE; Barnieh LJ; Kappel J; Manns BJ; Samuel SM; Jun M; Weaver R; Valk N; Hemmelgarn BR, 2016, 'The see kidney disease targeted screening program for CKD', Clinical Journal of the American Society of Nephrology, 11, pp. 964 - 972, http://dx.doi.org/10.2215/CJN.11961115

Turin TC; Jun M; James MT; Tonelli M; Coresh J; Manns BJ; Hemmelgarn BR, 2016, 'Magnitude of rate of change in kidney function and future risk of cardiovascular events', International Journal of Cardiology, 202, pp. 657 - 665, http://dx.doi.org/10.1016/j.ijcard.2015.09.090

Jun M; Manns B; Laupacis A; Manns L; Rehal B; Crowe S; Hemmelgarn BR, 2015, 'Assessing the extent to which current clinical research is consistent with patient priorities: A scoping review using a case study in patients on or nearing dialysis', Canadian Journal of Kidney Health and Disease, 2, http://dx.doi.org/10.1186/s40697-015-0070-9

Jun M; Turin TC; Woodward M; Perkovic V; Lambers Heerspink HJ; Manns BJ; Tonelli M; Hemmelgarn BR, 2015, 'Assessing the validity of surrogate outcomes for ESRD: A meta-analysis', Journal of the American Society of Nephrology, 26, pp. 2289 - 2302, http://dx.doi.org/10.1681/ASN.2014040396

Hillis GS; Welsh P; Chalmers J; Perkovic V; Chow CK; Li Q; Jun M; Neal B; Zoungas S; Poulter N; Mancia G; Williams B; Sattar N; Woodward M, 2015, 'Erratum. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients With type 2 diabetes. Diabetes Care 2014;37:295-303', Diabetes Care, 38, pp. 1393, http://dx.doi.org/10.2337/dc15-er07

Back to profile page